Member Info for Longish

Maybe Shett bought his own shares back from the bank and difference is increased interest charges through the profit and loss account to be charged to directors remuneration. We just don't know. Sorrel thought he still owned WPP and treated it accordingly.

Did the ex directors have additional shares with a 90 and 180 day block to sell. That still apply?

Got out of Finablr because they are still directors. Could buy back cheaper today..

Crikey adzy, Mr Khalid gonna end with an umbrella up his jacksie and delivering on line lectures outside the UAE/Bahrain etc. But nmc on the FTSE - must be some complicity from UK parties or nmc simply failed to keep an up to date share register..

I am breskeven here again. Out of Finablr as they are still directors. Risk 50:50 they been naughtier than we think

I suppose Shetty could take this private. Would balance out nmc debacle which appears only share register admin related.

So why we up?...cant complain

Need that CEO and hope he/she is not interested in database administration. What a useless update

If it was valued at a multiple of annual revenue, I cant see anyone expecting to get it less than £15. Regional healthcare interests not withstanding...

Thanks RKB. There was an RNS during the week so the news is in the SP already imo. I would bet the missing shares are held by a member of the royal family and a sharia law problem. If so, be surprised if they sell now. Share overhang may quickly turn to drought....

Didnt think there was any problem with the two brothers. As far as I can tell its Buttis Private Equity model and UAE government insurance reimbursement. Has UAE effectively underwritten £12 SP with NMC 40% trading margins (Mediclinic 7%) as MW claims or is Butti rogue? I guess its no coincidence the OECD just published 'long term care and health insurance in oecd and other countries' and the finance models used by different countries (fees for service etc).

10% up on the low and been tested with corporate governance news Volatile for sure.

ANTA recovered to 30% above price when MW attacked. That was a chinese company if any relevance.

If they take a position and increase the SP 40% thats +ve. Activist investors?

What SP will a takeover start and what if private equity?
1 years revenue c.$2.1Bn (2018)
Current market value $1.6Bn
Total assets $3.9Bn, Net assets $1.4Bn (2018)
Takeover Code imo possible cash SP over last 3 months Nov £25, Dec £17, Jan £15, Feb £?

The City Code - three underlying principles currently ar work:
1.) all shareholders of the same class in a target company must be treated equally and must have
adequate information so that they can reach a properly informed decision;
2.) a false market must not be created in the securities of the offeror or the target company; and
3.) the management of the target company must not take any action which would frustrate an
offer without the consent of its shareholders.

This is the link to article. Sunday is the '1st business day' so 'next week' starts tommorrow, Sunday
https://www.standard.co.uk/business/activist-investor-krupa-global-investments-sets-up-nmc-backer-talks-a4361501.html

...and all NMCs benchmark healthcare operators like mediclinic etc are only reporting ifrs16 for the 1st time in
2019 with adjustments to their reported margins, ebitda etc already eing indicated.

Could backfire on US and its industry reporting on supply chains imo

NMC used as a stalking horse for adoption of a common international reporting standard maybe

Understanding how and why some of NMC’s suppliers use Supply Chain Financing

https://cf-cdn.nmc.ae/Uploads/InvestorRelations/governance-initiatives-update-11-nov-2019-07fd2090-7ae1-4029-960e-aef866042520.pdf

Chris-
'My general view is that the initial MW report - which was really about operational concerns (and purported issues with the business eg margin etc - noting there was an assumed link to related party transactions) is now being conflated with governance / shareholder concerns - I still view them as separate.'

MW said
'We believe that a significant part of the reason for this outperformance is NMC materially underreports its rejection rate for reimbursement, thereby inflating its reported margin. Another factor that could be assisting this inflation is purchases from related parties – we do not advise investors to be sanguine about this possibility, as the price to be paid for what could perhaps be perceived as a subsidy from the privately-owned businesses – could very well be overpayment for long-term assets and capex.'

I wrap this issue up in IFRS 16 and one for the auditors and director governance obligations. Otherwise it might be fraud and the Freeh report. Interesting to see what order these reports come out. I dont think we see the audit report on 5th March. Anyone?

Deos 'I first bought 2 weeks ago at £13' typo me thinks?